- Home
- BHVN vs EOS Comparison
BHVN vs EOS Comparison
Compare BHVN & EOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- EOS
- Stock Information
- Founded
- BHVN 2013
- EOS 2005
- Country
- BHVN United States
- EOS United States
- Employees
- BHVN N/A
- EOS N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- EOS Trusts Except Educational Religious and Charitable
- Sector
- BHVN Health Care
- EOS Finance
- Exchange
- BHVN Nasdaq
- EOS Nasdaq
- Market Cap
- BHVN 1.5B
- EOS 1.3B
- IPO Year
- BHVN 2017
- EOS N/A
- Fundamental
- Price
- BHVN $15.66
- EOS $23.84
- Analyst Decision
- BHVN Strong Buy
- EOS
- Analyst Count
- BHVN 14
- EOS 0
- Target Price
- BHVN $54.62
- EOS N/A
- AVG Volume (30 Days)
- BHVN 2.3M
- EOS 84.1K
- Earning Date
- BHVN 08-11-2025
- EOS 01-01-0001
- Dividend Yield
- BHVN N/A
- EOS 6.80%
- EPS Growth
- BHVN N/A
- EOS N/A
- EPS
- BHVN N/A
- EOS N/A
- Revenue
- BHVN N/A
- EOS N/A
- Revenue This Year
- BHVN N/A
- EOS N/A
- Revenue Next Year
- BHVN $1,007.82
- EOS N/A
- P/E Ratio
- BHVN N/A
- EOS N/A
- Revenue Growth
- BHVN N/A
- EOS N/A
- 52 Week Low
- BHVN $12.79
- EOS $15.62
- 52 Week High
- BHVN $55.70
- EOS $20.63
- Technical
- Relative Strength Index (RSI)
- BHVN 56.24
- EOS 47.86
- Support Level
- BHVN $14.23
- EOS $23.40
- Resistance Level
- BHVN $16.14
- EOS $24.36
- Average True Range (ATR)
- BHVN 0.86
- EOS 0.25
- MACD
- BHVN 0.10
- EOS -0.06
- Stochastic Oscillator
- BHVN 85.48
- EOS 45.83
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About EOS Eaton Vance Enhance Equity Income Fund II
Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. It invests in a portfolio of large and mid-cap securities in sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.